Middleton RJ, Foley RN, Hegarty J, Cheung CM, McElduff P, Gibson JM, et al
Latin America held a 3% share of the market in 2025 and is expected to grow at a significant CAGR of 14% during the projection period, driven by GLP-1 medications that are driving structural health and economic shifts across Latin America by curbing surging obesity and type-2 diabetes rates, spurring vast biopharma investments, and fundamentally changing consumer habits in the fast-moving consumer goods sector
Beyond general food preferences, GLP-1 RA therapy also appears to modulate sensory responses
For example, short acting insulin or basal insulin adjustments can address gaps while oral agents are held
5 Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Correspondence: Phisit Khemawoot, Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Tel/Fax +66 28395161, Email [email protected] Background: Our previous studies in vitro and in vivo have shown anti-severe acute respiratory syndrome coronavirus 2 activity of fingerroot extract ( Boesenbergia rotunda ) and its phytochemical panduratin A
